Sunshine Biopharma (SBFM) Current Assets (2016 - 2025)
Historic Current Assets for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to $28.0 million.
- Sunshine Biopharma's Current Assets rose 764.14% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 764.14%. This contributed to the annual value of $26.0 million for FY2024, which is 432.42% up from last year.
- Latest data reveals that Sunshine Biopharma reported Current Assets of $28.0 million as of Q3 2025, which was up 764.14% from $27.9 million recorded in Q2 2025.
- Sunshine Biopharma's 5-year Current Assets high stood at $42.0 million for Q2 2022, and its period low was $1.8 million during Q2 2021.
- For the 5-year period, Sunshine Biopharma's Current Assets averaged around $22.1 million, with its median value being $25.7 million (2024).
- Per our database at Business Quant, Sunshine Biopharma's Current Assets soared by 531351.14% in 2021 and then plummeted by 3784.44% in 2023.
- Over the past 5 years, Sunshine Biopharma's Current Assets (Quarter) stood at $2.2 million in 2021, then surged by 1143.83% to $27.3 million in 2022, then dropped by 8.87% to $24.9 million in 2023, then grew by 4.32% to $26.0 million in 2024, then rose by 7.71% to $28.0 million in 2025.
- Its Current Assets stands at $28.0 million for Q3 2025, versus $27.9 million for Q2 2025 and $24.5 million for Q1 2025.